MR
MRMD.US Marimed Inc
- Market cap
- USD 28.3M
- P/E
- -
- P/B
- 0.63x
- ROE
- -32.7%
- Dividend yield
- 0.48%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is MRMD.US undervalued?
Graham numberThe Graham number of Marimed Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Marimed Inc fundamental analysis
No fundamental analysis for Marimed Inc yet.
Marimed Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Marimed Inc
MariMed Inc. engages in cultivation, production, and selling of branded cannabis products in the United States. The company sells cannabis flower, vapes, and concentrates under the Nature's Heritage brand; and cannabis fruit chews that delivers better sleep, pain relief, stress relief, and others under Betty's Eddies brand. It offers soft and chewy baked goods and a hot chocolate mix under Bubby's Baked brand; cannabis-infused hydrating drink mix for discrete and on-the-go c…
Full company profileMarimed Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Marimed Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 3.56M | 6.07M | 11.9M | 45.6M | 50.9M | 121M | 134M | 149M | 158M | 160M | 163M |
| Gross Profit | 2.21M | 3.51M | 7.81M | 18.7M | 31.3M | 66.3M | 64.0M | 65.9M | 62.6M | 57.9M | 63.0M |
| Operating Income | 612K | 128K | -4.02M | 5.60M | 14.5M | 26.9M | 20.4M | 15.2M | 3.22M | -752K | 2.82M |
| EBITDA | - | -155K | -8.28M | -68.0M | 16.5M | 29.0M | 25.9M | 11.2M | 13.5M | 8.15M | 14.7M |
| Net Income | -199K | -1.19M | -13.6M | -81.2M | 2.14M | 7.22M | 13.5M | -16.0M | -12.5M | -14.5M | -14.7M |
| EPS | - | -0.01 | -0.06 | -0.36 | 0.01 | 0.02 | 0.04 | -0.04 | -0.03 | -0.04 | -0.04 |
| Balance Sheet | |||||||||||
| Total Assets | 8.56M | 32.2M | 83.0M | 61.6M | 76.4M | 123M | 152M | 196M | 207M | 203M | 197M |
| Total Liabilities | 9.11M | 21.2M | 21.2M | 55.2M | 53.6M | 49.2M | 57.2M | 126M | 147M | 153M | 154M |
| Shareholders' Equity | -551K | 11.0M | 61.8M | 6.33M | 22.8M | 74.0M | 95.0M | 69.9M | 59.9M | 50.0M | 45.1M |
| Cash & Short-term Investments | 0.00 | 0.00 | 0.00 | 739K | 4.36M | 29.9M | 9.86M | 14.6M | 7.28M | 8.88M | 8.44M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -198K | 1.76M | -2.91M | -24.1M | 3.38M | 35.9M | 7.31M | 7.91M | 6.79M | 7.70M | 6.34M |
| Capital Expenditure | 3.36M | 21.0M | 8.92M | 9.67M | 4.69M | 17.9M | 12.1M | 20.8M | 12.7M | 1.63M | 2.50M |
| Free Cash Flow | - | -19.7M | -11.8M | -34.1M | -1.56M | 17.3M | -5.43M | -12.8M | -5.89M | 6.06M | 3.83M |
| Ratios | |||||||||||
| ROE | - | -10.8% | -22.0% | -1,282.9% | 9.4% | 9.8% | 14.2% | -22.9% | -20.8% | -29.0% | -32.7% |
| ROA | -2.3% | -3.7% | -16.4% | -131.9% | 2.8% | 5.9% | 8.8% | -8.2% | -6.0% | -7.2% | -7.5% |
| Net Profit Margin | -5.6% | -19.7% | -114.8% | -178.0% | 4.2% | 5.9% | 10.0% | -10.8% | -7.9% | -9.1% | -9.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Marimed Inc dividends
- Dividend yield
- 0.48%
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 137K | 0.00 | - |
| 2024 | USD 139K | 0.00 | - |
| 2023 | USD 158K | 0.00 | - |
| 2022 | USD 259K | 0.00 | 1.9% |
| 2021 | USD 410K | 0.00 | 5.7% |
| 2020 | USD 309K | 0.00 | 14.4% |
| 2019 | USD 410K | 0.00 | - |
| 2018 | USD 410K | 0.00 | - |
| 2017 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Marimed Inc
- Insiders 14.63%
- Institutions 0.82%
- Public & others 84.54%
- Shares outstanding 404M
- Free float 336M
Marimed Inc company profile
- Company name
- Marimed Inc
- Ticker
- MRMD.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Employees
- 808
- Fiscal year end
- December
- Address
- 10 Oceana Way, Norwood, MA, United States, 02062
- Phone
- 781 277 0007
- Website
- marimedinc.com
About Marimed Inc
MariMed Inc. engages in cultivation, production, and selling of branded cannabis products in the United States. The company sells cannabis flower, vapes, and concentrates under the Nature's Heritage brand; and cannabis fruit chews that delivers better sleep, pain relief, stress relief, and others under Betty's Eddies brand. It offers soft and chewy baked goods and a hot chocolate mix under Bubby's Baked brand; cannabis-infused hydrating drink mix for discrete and on-the-go consumption under Vibations brand; and flower, vapes, and edibles under InHouse brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is headquartered in Norwood, Massachusetts.
Marimed Inc management
7- Mr. Jon R. LevineCo-Founder, CEO, President, Secretary, Treasurer & Director · born 1965
- Mr. Timothy ShawChief Operating Officer · born 1978
- Mr. Ryan CrandallChief Commercial Officer · born 1979
- Mr. Mario PinhoChief Financial Officer · born 1968
- Mr. Howard SchacterChief Communications Officer
- Ms. Marlo RichardVice President of Human Resources
- Alexander SwartzRetail Director of Mid-Atlantic